The ROE (Return on Equity) of Cosmo Pharmaceuticals NV (COPN.SW) is 26.74%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2024-12-31 | 26.74% |
| 2023-12-31 | -2.72% |
| 2022-12-31 | 3.77% |
| 2021-12-31 | 4.29% |
| 2020-12-31 | -1.97% |
| 2019-12-31 | -6.20% |
| 2018-12-31 | -4.06% |
| 2017-12-31 | -6.90% |
| 2016-12-31 | 4.65% |
| 2015-12-31 | 61.49% |